He looks like a hot water bottle stuffed with bowling balls, an 80s action figure with more veins — an improbably muscular ...

IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...

Arthritic hips are no walk in the park. The first signs of trouble can creep up subtly with morning pain and stiffness.

"We were pleased that blinded data from the ongoing Phase 2 trial of BRTX-100 in cLDD continues to be in-line to meet the primary safety endpoint of study, and that the positive preliminary efficacy ...

Eating a placenta may not give you the health benefits some people want you to believe it has, but using it as a bandage ...

In March 2025, the European Patent Office issued a Notice of Allowance for a new patent application (European Patent Appl. No. 20798130.9) covering key aspects of BioRestorative’s allogeneic, ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

As demand grows exponentially, donation rates remain low and thousands await an organ for a second chance at life ...

Stem cell injections, platelet rich plasma and ivermectin do big business despite dubious or no evidence supporting their use in rheumatology. However, far from being a recent development, this type ...

Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...

Long-Term Survival Rates of Some Acute Myeloid Leukemia Patients Could Double With Sensitive Bone Marrow Test Apr. 28, 2025 — A highly sensitive bone marrow test could double survival rates for ...